Clinical Trials Browser

Suspended × Sarcoma × pembrolizumab × Clear all

NCT07283731 2026-04-06

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

Phase 2 Suspended

Neoplasm Metastasis, Sarcoma